‘Patient Capital’ Backing LSE Debutant As It Eyes A Multi-Billion Pound Prize LONDON Stock Exchange debutant Oxford Cannabinoid Technologies is aiming to emulate the success of GW Pharmaceuticals. Its founders Gavin Sathianathan… By hempcbdtimes , in casa verde capital Company Stories Dr John Lucas Imperial Brands Oxford Cannabinoid Technologies oxford university , at May 26, 2021